ELF•November 22, 2026 at 6:34 AM UTCHousehold & Personal Products

e.l.f. Beauty Bullish Article Doesn't Change Cautious Valuation Call

Read source article

What happened

e.l.f. Beauty released a Motley Fool article highlighting that management raised its full-year sales outlook, driven by the Rhode acquisition and resilient organic growth, with international expansion still in early stages. The latest DeepValue master report, however, maintains a cautious 'potential sell' rating, noting that the revised guidance still implies only 3-4% organic growth excluding Rhode and flat adjusted EBITDA, while the stock trades at a rich 64x trailing earnings and 28x EV/EBITDA. The market has punished the shares after fiscal Q2 2026 results, with the price falling from over $140 in September 2025 to around $89 by mid-January 2026, reflecting concerns about China tariffs, margin compression, and elevated marketing costs. While the publication offers a credible bull case centered on integration and global expansion, it largely reiterates management's own positive framing without addressing the structural headwinds that could offset those gains. Consequently, the article does not materially alter the investment thesis, which remains tilted toward waiting for a valuation reset or trimming exposure above $105.

Implication

The Motley Fool's positive piece underscores real strengths—Rhode's scale potential and early international traction—but it does not change the fact that ex-Rhode organic growth is merely low-single-digit and gross margins are pressured by elevated China tariffs. At ~64x trailing EPS, the stock prices in a quick return to mid-teens growth and 70%+ gross margins that the company's own guidance does not support, leaving little margin of safety. Near-term catalysts include Q3 FY26 results and initial sell-through data from Rhode's Sephora and Mecca launches; strong execution could reignite multiple expansion, while any shortfall would likely trigger further derating. Given the high degree of uncertainty and the stock's recent volatility, investors should avoid adding new positions and instead use bounces to reduce exposure, while monitoring organic growth re-acceleration and tariff mitigation as key swing factors. Only a decisive beat on organic growth, gross margin, and Rhode's ramp—or a material price decline toward the mid-$60s—would shift the risk-reward in favor of new buying.

Thesis delta

The new article introduces a more bullish near-term growth narrative, but it does not significantly alter the master report's cautious thesis, which hinges on valuation and margin sustainability. Management's raised sales outlook, while positive, relies heavily on Rhode and does not resolve the core issue of low organic growth and tariff-driven cost pressure. Thus, the thesis shift is minimal: the bull case gains slightly from international expansion optionality, but the bear case remains intact, and the recommended action stays defensive.

Confidence

Medium